Cytotoxic effects of psychotropic benzofuran derivatives,<i>N</i>-methyl-5-(2-aminopropyl)benzofuran and its<i>N</i>-demethylated derivative, on isolated rat hepatocytes

Albano, 1985, Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity, Mol. Pharmacol., 28, 306

Andreu, 1998, Ecstasy: a common cause of severe acute hepatotoxicity, J. Hepatol., 29, 394, 10.1016/S0168-8278(98)80056-1

Arora, 1997, Ceramide induces hepatocytes cell death through disruption of mitochondrial function in the rat, Hepatology, 25, 958, 10.1002/hep.510250428

Barbosa, 2015, Mitochondria: key players in the neurotoxic effects of amphetamines, Arch. Toxicol., 89, 1695, 10.1007/s00204-015-1478-9

Bellomo, 1990, The cytoskeleton as a target in quinone toxicity, Free Radic. Res. Commun., 8, 391, 10.3109/10715769009053373

Bosser, 1995, Liver cell necrosis: cellular mechanisms and clinical implications, Gastroenterology, 108, 252, 10.1016/0016-5085(95)90032-2

Brown, 2003, Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress, Pharmacol. Ther., 99, 45, 10.1016/S0163-7258(03)00052-4

Cain, 1987, Biochemical Toxicology, A Practical Approach, 217

Carvalho, 2002, Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells, Arch.Toxicol., 76, 581, 10.1007/s00204-002-0381-3

Carvalho, 2004, Hepatotoxicity of 3,4-methylenedioxy-amphetamine α-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates, Arch. Toxicol., 78, 16, 10.1007/s00204-003-0510-7

Connelly, 2002, Application of directly coupled high performance liquid chromatography-NMR-mass spectrometry and 1H NMR spectroscopic studies to the investigation of 2,3-benzofuran metabolism in Sprague-Dawley rats, Drug Metab. Dispos., 30, 1357, 10.1124/dmd.30.12.1357

Custódio, 2010, Comparative effects of 3,4-methylenedioxymethamphetamine and 4-methylthioamphetamine on rat liver mitochondrial function, Toxicology, 270, 99, 10.1016/j.tox.2010.01.022

Dar, 1996, MDMA induced hyperthermia: report of a fatality and review of current therapy, Intensive Care Med., 22, 995, 10.1007/BF02044131

Davidson, 2001, Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment, Brain Res. Rev., 36, 1, 10.1016/S0165-0173(01)00054-6

Dias da Silva, 2013, An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis, Arch. Toxicol., 87, 2165, 10.1007/s00204-013-1082-9

Eskandari, 2014, A new approach on methamphetamine-induced hepatotoxicity: involvement of mitochondrial dysfunction, Xenobiotica, 44, 70, 10.3109/00498254.2013.807958

Fusi, 1992, Interaction of butylated hydroxyanisole with mitochondrial oxidative phosphorylation, Biochem. Pharmacol., 43, 1203, 10.1016/0006-2952(92)90493-3

Fuwa, 2016, Novel psychoactive benzofurans strongly increase extracellular serotonin level in mouse corpus striatum, J. Toxicol. Sci., 41, 329, 10.2131/jts.41.329

Griffiths, 1995, Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion, Biochem. J., 307, 93, 10.1042/bj3070093

Gunter, 1990, Mechanism by which mitochondria transport calcium, Am. J. Phys., 258, C755, 10.1152/ajpcell.1990.258.5.C755

Hall, 2006, Acute toxic effects of “Ecstasy” (MDMA) and related compounds: overview of pathophysiology and clinical management, Br. J. Anaesth., 96, 678, 10.1093/bja/ael078

Hegadoren, 1999, 3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans, Neurosci. Biobehav. Rev., 23, 539, 10.1016/S0149-7634(98)00046-3

Henry, 1992, Toxicity and deaths from 3,4-methylenedioxymethanphetamine (“ecstasy”), Lancet, 340, 384, 10.1016/0140-6736(92)91469-O

Horobin, 2015, Predicting mitochondrial targeting by small molecule xenobiotics with living cells using QSAR models, Methods Mol. Biol., 1265, 13, 10.1007/978-1-4939-2288-8_2

Huang, 1993, Nickel induces increased oxidants in intact cultured mammalian cells as detected by dichlorofluorescein fluorescence, Toxicol. Appl. Pharmacol., 120, 29, 10.1006/taap.1993.1083

Iversen, 2013, Neurochemical profiles of some novel psychoactive substances, Eur. J. Pharmacol., 700, 147, 10.1016/j.ejphar.2012.12.006

Jones, 1981, Determination of pyridine dinucleotides in cell extracts by high-performance liquid chromatography, J. Chromatogr., 225, 446, 10.1016/S0378-4347(00)80293-5

Jones, 1999, Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications, Aliment. Pharmacol. Ther., 13, 129, 10.1046/j.1365-2036.1999.00454.x

Kehrer, 1990, Mechanisms of hypoxic cell injury. Summary of the symposium presented at the 1990 Annual Meeting of the Society of Toxicology, Toxicol. Appl. Pharmacol., 106, 165, 10.1016/0041-008X(90)90238-P

Kroemer, 1999, Mitochondrial control of apoptosis: an overview, Biochem. Soc. Symp., 66, 1, 10.1042/bss0660001

Lemasters, 1993, Mitochondrial Dysfunction, 404, 10.1016/B978-0-12-461205-1.50040-0

Lemasters, 1997, The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury, Mol. Cell. Biochem., 174, 159, 10.1023/A:1006827601337

Liechti, 2015, Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling, Swiss Med. Wkly., 145, w14043

Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6

Meylan, 1995, Atom/fragment contribution method for estimating octanol-water partition coefficients, J. Pharm. Sci., 84, 83, 10.1002/jps.2600840120

Milroy, 1996, Pathology of deaths associated with “ecstasy” and “eve” misuse, J. Clin. Pathol., 49, 149, 10.1136/jcp.49.2.149

Moldéus, 1978, Isolation and use of liver cells, Methods Enzymol., 52, 60, 10.1016/S0076-6879(78)52006-5

Muller, 2004, Complex III releases superoxide to both sides of the inner mitochondrial membrane, J. Biol. Chem., 279, 49064, 10.1074/jbc.M407715200

Nakagawa, 1998, Mechanism of p-hydroxybenzoate ester-induced mitochondrial dysfunction and cytotoxicity in rat hepatocytes, Biochem. Pharmacol., 55, 1907, 10.1016/S0006-2952(98)00097-5

Nakagawa, 1999, Role of mitochondrial membrane permeability transition in p-hydroxybenzoate ester-induced cytotoxicity in rat hepatocytes, Biochem. Pharmacol., 58, 811, 10.1016/S0006-2952(99)00147-1

Nakagawa, 2009, Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes, Arch. Toxicol., 83, 69, 10.1007/s00204-008-0323-9

Nicotera, 1992, Calcium-mediated mechanisms in chemically induced cell death, Annu. Rev. Pharmacol. Toxicol., 32, 447, 10.1146/annurev.pa.32.040192.002313

Ninković, 2004, N-methyl-4-methylenedioxyamphetamine-induced hepatotoxicity in rats: oxidative stress after acute and chronic administration, Vojnosanit. Pregl., 61, 125, 10.2298/VSP0402125N

Petronilli, 1994, The voltage sensor of the mitochondrial permeability transition pore is turned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidation and its reversal by reducing agents, J. Biol. Chem., 269, 16638, 10.1016/S0021-9258(19)89437-1

Reed, 1980, High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide and related thiols and disulfides, Anal. Biochem., 106, 55, 10.1016/0003-2697(80)90118-9

Rickli, 2015, Pharmacological profile of novel psychoactive benzofurans, Br. J. Pharmacol., 172, 3412, 10.1111/bph.13128

Shen, 1996, Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1, Free Radic. Biol. Med., 21, 139, 10.1016/0891-5849(96)00019-6

Trost, 1996, The mitochondrial permeability transition: a new pathophysiological mechanism for Rey's syndrome and toxic liver injury, J. Pharmacol. Exp. Ther., 278, 1000

Wallace, 1997, Mitochondria-mediated cell injury. Symposium overview, Fundam. Appl. Toxicol., 38, 23, 10.1006/faat.1997.2320

Walubo, 1999, Fatal multi-organ failure after suicidal overdose with MDMA, “ecstasy”: case report and review of the literature, Hum. Exp. Toxicol., 18, 119, 10.1191/096032799678839707

Wang, 1999, Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader, Free Radic. Biol. Med., 27, 612, 10.1016/S0891-5849(99)00107-0

Welter, 2015, Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MSn techniques, Anal. Bioanal. Chem., 407, 1371, 10.1007/s00216-014-8360-0

Zalis, 1967, The pathophysiology of acute amphetamine poisoning with pathologic correlation, J. Pharmacol. Exp. Ther., 158, 115

Zhang, 2001, Mitochondrial electron transport inhibitors cause lipid peroxidation-dependent and -independent cell death: protective role of antioxidants, Arch. Biochem. Biophys., 393, 87, 10.1006/abbi.2001.2486